Israel's Innovation Authority allocates $500M+ annually in non-dilutive conditional royalty grants across the full innovation lifecycle — from proof-of-concept to multinational R&D co-operation — underpinning Israel's Start-Up Nation status and world-highest VC investment per capita.
Israel's primary government body for technological innovation allocates $500M+ annually across the innovation lifecycle — from pre-seed proof-of-concept to multinational R&D co-operation agreements. Its non-dilutive conditional-royalty model (no equity taken; grants repaid only if the product generates revenue) underpins Israel's "Start-Up Nation" reputation and world-highest VC investment per capita.
Funding tracks include early-stage R&D (up to 50% of costs), deep tech (up to 60%), manufacturing tech, and R&D centre support for multinationals. Grants convert to royalties at 3–5% of revenue until repaid. Innovation Labs support specific verticals: agri-tech, medical, cybersecurity, and autonomous vehicles.
Israeli-registered companies of all sizes, from seed-stage startups to large enterprises. International companies with Israeli R&D centres are also eligible for the multinational R&D centre track.
Rolling applications at innovationisrael.org.il. Each track has its own submission window, budget, and committee review cycle. No advance payment required; disbursements tied to R&D milestones.